Exencial Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,412
| Closed | -$213K | – | 479 |
|
|
2024
Q1 | $213K | Buy |
7,412
+276
| +4% | +$7.94K | 0.01% | 474 |
|
|
2023
Q4 | $234K | Sell |
7,136
-715
| -9% | -$23.5K | 0.01% | 446 |
|
|
2023
Q3 | $219K | Sell |
7,851
-7
| -0.1% | -$195 | 0.01% | 397 |
|
|
2023
Q2 | $268K | Sell |
7,858
-2,407
| -23% | -$82.1K | 0.01% | 386 |
|
|
2023
Q1 | $309K | Buy |
10,265
+1,422
| +16% | +$42.8K | 0.02% | 346 |
|
|
2022
Q4 | $250K | Sell |
8,843
-428
| -5% | -$12.1K | 0.01% | 378 |
|
|
2022
Q3 | $305K | Sell |
9,271
-207
| -2% | -$6.81K | 0.02% | 337 |
|
|
2022
Q2 | $298K | Sell |
9,478
-171
| -2% | -$5.38K | 0.02% | 346 |
|
|
2022
Q1 | $443K | Buy |
9,649
+53
| +0.6% | +$2.43K | 0.02% | 298 |
|
|
2021
Q4 | $588K | Buy |
+9,596
| New | +$588K | 0.03% | 284 |
|
|
2021
Q3 | – | Sell |
-12,089
| Closed | -$1.12M | – | 330 |
|
|
2021
Q2 | $1.12M | Hold |
12,089
| – | – | 0.06% | 224 |
|
|
2021
Q1 | $1.07M | Buy |
12,089
+1,184
| +11% | +$105K | 0.06% | 211 |
|
|
2020
Q4 | $1.02M | Buy |
10,905
+2,075
| +23% | +$194K | 0.07% | 196 |
|
|
2020
Q3 | $563K | Buy |
8,830
+279
| +3% | +$17.8K | 0.03% | 243 |
|
|
2020
Q2 | $446K | Buy |
+8,551
| New | +$446K | 0.04% | 228 |
|